Significant Ownership of HBM Healthcare Investments (Cayman) Ltd.

Signature - Title
/s/ Jean-Marc LeSieur - Jean-Marc LeSieur, Managing Director
Location
Grand Cayman, Cayman Islands
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by HBM Healthcare Investments (Cayman) Ltd..

Notify me when HBM Healthcare Investments (Cayman) Ltd. files a new Schedule 13D/G report.

⭐ Subscribe ⭐

Significant Ownership of HBM Healthcare Investments (Cayman) Ltd.

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
ALXO ALX ONCOLOGY HOLDINGS INC Common Stock, par value $0.001 per share 8.4% $2,295,000 +$547,266 4,500,000 +31% HBM Healthcare Investments (Cayman) Ltd. 31 Mar 2025
IOBT IO Biotech, Inc. Common Stock, par value $0.001 per share 8.2% $5,412,970 5,523,439 HBM Healthcare Investments (Cayman) Ltd. 31 Dec 2023
IMRX Immuneering Corp Class A Common Stock, par value $0.001 per share 5.7% $29,680,915 3,646,304 HBM Healthcare Investments (Cayman) Ltd. 26 Sep 2025
AVBP ArriVent BioPharma, Inc. Common Stock, par value $0.0001 per share 5.4% $40,491,643 2,195,014 HBM Healthcare Investments (Cayman) Ltd. 08 Oct 2025
BNTC Benitec Biopharma Inc. Common Stock, par value $0.0001 per share 4.5% $14,156,282 1,041,669 HBM Healthcare Investments (Cayman) Ltd. 31 Dec 2024
UPB Upstream Bio, Inc. Common Stock, par value $0.001 per share 4.1% $41,290,257 -$9,780,217 2,195,111 -19% HBM Healthcare Investments (Cayman) Ltd. 30 Sep 2025
YMAB Y-mAbs Therapeutics, Inc. Common Stock, $0.0001 par value 0% $0 0 HBM Healthcare Investments (Cayman) Ltd. 30 Sep 2025

Schedules 13D/G Reported by HBM Healthcare Investments (Cayman) Ltd.:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Filing Date
* An asterisk sign (*) next to the price indicates that the price is likely invalid.